Latest biotechnology News | Page 9

Regulatory changes for medical device clinical trials not needed
Slippery slope – basic research underfunded in Australia
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Assessors needed for industry PhD program
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
Pharmaxis adds combination arm to PXS‐5505 myelofibrosis study
Focus turns to all things medtech
Immutep announces changes to its board of directors
Recce Pharmaceuticals announces planned grant of ‘Patent Family 4’ for anti-infectives
ATSE seek views on commercialisation
Brain Prize winner to speak on brain’s control of locomotion
Emyria and Aspen Australia sign binding licensing and commercialisation term sheet
Pitch your early-stage medtech
New superlab to put Victoria at the forefront of life sciences
FY2022 STAR grant recipients selected
Attention plant killers: new research shows your plants could be silently screaming at you
Industry groups welcome Senate backing of National Reconstruction Fund
IDT achieves milestone with TGA-approved expansion of manufacturing
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
AusMedtech goes back to future
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
Directory of Australian accelerators and incubators launched
Brandon BioCatalyst with ANDHealth to deliver BioMedTech Incubator Program
Support for passage of NRF legislation through Senate
Investigating the Effects on Amide-to-Ester Substitutions on Membrane Permeability of Cyclic Peptides
Interim analysis shows accuracy of Optiscan Imaging platform
Proteomics says it will resubmit PromarkerD predictive test for Medicare funding
Patrys’ says preclinical data supports synthetic lethality mechanism
Call for speakers for biggest week in biotech
MRFF back Monash mRNA researchers
Immutep announces initiation of new breast cancer trial
Mark Butler announces funding for mitochondrial donation pilot program
National Reconstruction Fund moves closer to reality
Exposing tumours to bacteria converts immune cells to cancer killers
If we perfect cultivated meat, we could hedge against food shortages as climate chaos intensifies
Exposing cancers to bacteria reminds first responder immune
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
Biotech stocks back on road to recovery, according to latest report
Biotechnologist and Social Scientist honoured in WA Womens Hall of Fame
Emyria partners with specialist trauma psychiatric service to advance MDMA-assisted therapy
GreenLight Clinical and Cure Therapeutics look to future collaboration
Starpharma announces appointment of chief financial officer
Embracing equity in life sciences sector
Industry and Science Minister Ed Husic’s Welcome speech to Science Meets Parliament 2023
Microba Life Sciences announces new distribution agreements in Europe
Neuren Pharmaceuticals appoints experienced industry executive to board
Australian Cell and Gene Catalyst takes step forward